Smith Nephew Oxinium Knee Replacement

Consumer Alert: Smith & Nephew Issues a Recall on Oxinium Cementless Knee Replacements

Smith & Nephew, the international medical device conglomerate, headquartered in London, England, researches, develops, and markets medical orthopedic, endoscopic, and wound management products to medical communities throughout the world. Smith & Nephew developed cementless knee replacement implants, known as Oxinium Genesis II and Oxinium Profix II.

These Oxinium knee components worked more efficiently than the original metal cobalt chrome or titanium knee replacements of the past. The Oxinium implants reduce the amount of rubbing and resistance between the replacement components and surrounding tissue areas [i].

In the past, cobalt chrome or titanium based metals were considered the best material for knee replacements because of wear resistance. However, recent studies indicate that cobalt chrome femoral implants wear over time [ii]. When cobalt chrome or titanium is exposed to large amounts of stress from daily activity such as walking, it produces particles of matter, which produce inflammation known as osteolysis [iii].

The Oxinium knee replacement became a commonly used surgical procedure because of the increasing prevalence of knee replacement surgery; approximately 300,000 knee replacement procedures are performed in the United States annually. Approximately 3,000 patients had the Oxinium knee replacement [iv].

In August 2003, Smith & Nephew sent an alert to the US Food and Drug Administration after an Oxinium product defect was discovered [v]. Then, in September 2003, Smith & Nephew issued a recall on the design and function of the cementless knee implant in the United States. The macrotexturing surface failed to provide proper bonding to the bone, leading to increased pain and loosened knee joints. As of February 2005, approximately 26% (782 out of 2971 cases) of the Oxinium knee implants required revision surgery [v].

A number of these cementless knee implants are defective, causing increased amounts of pain, increased risks of revision surgery, infections, swelling and inflammation, more joint, tissue, and/or muscular damage, and increased rehabilitation.

Have you or a loved one had an Oxinium cementless knee replacement? Contact us.


  1. Smith & Nephew Product Portfolio. (2005). Orthopedics Oxinium Genesis II and Profix II Knee Systems. London, England
  2. Burns, Andrew. (2003). Smith & Nephew Advances Unicondylar Knee Surgery with Accuris Instrument and Oxinium Implant. London, England
  3. Cemented and Cementless Knee Replacements (2001). American Academy of Orthopedic Surgeons. Rosemont, IL
  4. Knee Replacement: Surgery Can Relieve Pain (October 2005); Mayo Clinic Health Information Division. Rochester, MN.
  5. Smith & Nephew: Risk Reports (2004 Annual Report). London, England
Contact Now
Image text Send e-mail
Jan 30 2015
Red Bank, N.J. – John E. Keefe, Jr. and Patrick J. Bartels announce Liana M. Nobile as new associate to Keefe Bartels. Liana concentrates her practice in class action and personal injury litigation.
Dec 15 2014
John Keefe, Jr. has been appointed member of a newly formed New Jersey Supreme Court committee that is set to examine ethical issues regarding lawyers' use of metadata. Click here to read more
Dec 02 2014
On Wednesday 12/3/2014 • 12PM, John E. Keefe, Jr. is presenting a NJICLE webinar on "Significant Developments in Class Actions". Click here for full details and to register. 
Nov 07 2014
Thousands of plaintiffs in New Jersey and around the country who had surgery to remove failed hip implants settled their claims on Nov. 3 in a deal that is expected to pay out more than $1 billion. View the full article here on the NJ Law Journal web site:
Nov 03 2014
John E. Keefe, Sr. and John E. Keefe, Jr. are scheduled to speak at the New Jersey State Bar Association Mid-Year meeting in Paris, France.
Oct 17 2014
October 23, 2014 • 6:00 pm - 11:00 pm C. Judson Hamlin to be honored at the Annual Brietkopf Award Dinner.
Oct 10 2014
As posted on Essex — An Essex County detective has lost his bid to overturn a $785,000 verdict against him in a case where jurors found he falsely arrested a Newark man for the murder of a woman in 2009. Click here for full story.
Sep 17 2014
Today marks the 6th annual National Mesothelioma Awareness Day, a day of remembrance and awareness of the disease that has tragically claimed the lives of so many.
Jul 28 2014
On July 28, 2014, the New Jersey Law Journal formally announced that attorney Joshua S. Kincannon is a recipient of one of this year’s New Leaders of the Bar award.  Admitted to the New Jersey Bar in 2000, Joshua Kincannon has established himself as an authority within the mass tort community. He has represented hundreds of plaintiffs and recovered millions of dollars on behalf of victims of defective products and medical devices.
Jun 29 2014
Newark, NJ:On June 26, 2014 an Essex County, New Jersey jury awarded a Newark man $785,000 for being wrongfully arrested and imprisoned for 490 days for crimes he did not commit. The plaintiff was represented by Patrick J. Bartels, Esq. and Jennifer Harwood Ruhl, Esq. of Keefe Bartels.
Subscribe to our eNews
For Email Marketing you can trust